Enhanced in vitro antiproliferative effects of EpCAM antibodyfunctionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells

Molecular Vision

Volumn 17, Issue , 2011, Pages 2724-2737

  Mitra, Moutushy ^a,c   Misra, Ranjita ^b   Harilal, Anju ^a   Sahoo, Sanjeeb K ^b   Krishnakumar, Subramanian ^a  

^a Vision Research Foundation   (India)

^b INSTITUTE OF LIFE SCIENCES   (India)

^c SASTRA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTIMITOTIC AGENT; CASPASE 3; NANOPARTICLE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PACLITAXEL; PACLITAXEL EPITHELIAL CELL ADHESION MOLECULE ANTIBODY CONJUGATE; POLYGLACTIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL ASSAY; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CONTROLLED STUDY; COVALENT BOND; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; ENDOCYTOSIS; ENZYME ACTIVATION; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; RETINA CELL; RETINOBLASTOMA;

ANTIBODIES; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASE 3; CELL ADHESION MOLECULES; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL SURVIVAL; CROSS-LINKING REAGENTS; DRUG CARRIERS; ENDOCYTOSIS; FLOW CYTOMETRY; HUMANS; IMMUNOCONJUGATES; LACTIC ACID; NANOPARTICLES; PACLITAXEL; PARTICLE SIZE; POLY(ADP-RIBOSE) POLYMERASES; POLYGLYCOLIC ACID; RETINAL NEOPLASMS; RETINOBLASTOMA;

EID: 83055198567     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Jain KK. Targeted drug delivery for cancer. Technol Cancer Res Treat 2005; 4:311-3. [PMID: 16029052]
2. Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 2002; 54:631-51. [PMID: 12204596]
3. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003; 55:329-47. [PMID: 12628320]
4. Sahoo SK, Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Discov Today 2003; 8:1112-20. [PMID: 14678737]
5. Wang C, Ho PC, Lim LY. Wheat germ agglutinin-conjugated PLGA nanoparticles for enhanced intracellular delivery of paclitaxel to colon cancer cells. Int J Pharm 2010; 400:201-10. [PMID: 20804835]
6. Chakravarthi SS, Robinson DH. Enhanced cellular association of paclitaxel delivered in chitosan-PLGA particles. Int J Pharm 2011; 409:111-20. [PMID: 21356285]
7. Danhier F, Vroman B, Lecouturier N, Crokart N, Pourcelle V, Freichels H, Jérôme C, Marchand-Brynaert J, Feron O, Préat V. Targeting of tumor endothelium by RGD-grafted PLGAnanoparticles loaded with paclitaxel. J Control Release 2009; 140:166-73. [PMID: 19699245]
8. Danhier F, Lecouturier N, Vroman B, Jérôme C, Marchand-Brynaert J, Feron O, Préat V. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. J Control Release 2009; 133:11-7. [PMID: 18950666]
9. BennsJMKimSWJTailoring new gene delivery designs for specific targets. JDrug Target.20008112 [PubMed: 10761641]
10. Faraasen S, Voros J, Csucs G, Textor M, Merkle HP, Walter E. Ligand-specific targeting of microspheres to phagocytes by surface modification with poly(L-lysine)-grafted poly(ethylene glycol) conjugate. Pharm Res 2003; 20:237-46. [PMID: 12636162]
11. Gao X, Cui Y, Levenson RM, Chung LWK, Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004; 22:969-76. [PMID: 15258594]
12. Raden D, Gilmore R. Signal recognition particle-dependent targeting of ribosomes to the rough endoplasmic reticulum in the absence and presence of the nascent polypeptideassociated complex. Mol Biol Cell 1998; 9:117-30. [PMID: 9436995]
13. Bellocq NC, Pun SH, Jensen GS, Davis ME. Transferrincontaining, cyclodextrin polymer-based particles for tumortargeted gene delivery. Bioconjug Chem 2003; 14:1122-32. [PMID: 14624625]
14. Krishnakumar S, Mohan A, Mallikarjuna K, Venkatesan N, Biswas J, Shanmugam MP, Ren-Heidenreich L. EpCAM expression in retinoblastoma: a novel molecular target for therapy. Invest Ophthalmol Vis Sci 2004; 45:4247-50. [PMID: 15557427]
15. Mitra M, Kandalam M, Verma RS. UmaMaheswari K, Krishnakumar S. Genome wide changes accompanying knock-down of Ep-CAM in retinoblastoma. Mol Vis 2010; 16:828-42. [PMID: 20461151]
16. Osta WA, Chen Y, Mikhitarian K, Mitas M, Salem M, Hannun YA, Cole DJ, Gillanders WE. Ep-CAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 2004; 64:5818-24. [PMID: 15313925]
17. Winter MJ, Nagtegaal ID, van Krieken JH, Litvinov SV. The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. Am J Pathol 2003; 163:2139-48. [PMID: 14633587]
18. Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer P. Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet 1979; 5:957-71. [PMID: 94699]
19. Kim SH, Jeong JH, Chun KW, Park TG. Target-Specific Cellular Uptake of PLGA Nanoparticles Coated with Poly(Llysine)-Poly(ethylene glycol)-Folate Conjugate. Langmuir 2005; 21:8852-7. [PMID: 16142970]
20. Parveen S, Moutushy M, Krishnakumar S, Sanjeeb KS. Enhanced Antiproliferative Activity of Carboplatin loaded Chitosan-Alginate Nanoparticles in Retinoblastoma Cell Line. Acta Biomater 2010; 6:3120-31. [PMID: 20149903]
21. Bhattacharyya S, Bhattacharya R, Curley S, McNiven MA, Mukherjee P. Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis. Proc Natl Acad Sci USA 2010; 107:14541-6. [PMID: 20679244]
22. Reddy JA, Low PS. Folate-mediated targeting of therapeutic and imaging agents to cancers. Crit Rev Ther Drug Carrier Syst 1998; 15:587-627. [PMID: 9883391]
23. Wartlick H, Michaelis K, Balthasar S, Strebhardt K, Kreuter J, Langer K. Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumor cells. J Drug Target 2004; 12:461-71. [PMID: 15621671]
24. Zhang Y, Zhang J. Surface modification of monodisperse magnetite nanoparticles for improved intracellular uptake to breast cancer cells. J Colloid Interface Sci 2005; 283:352-7. [PMID: 15721904]
25. Nam YS, Park JY, Han SH, Chang IS. New micelle-like polymer aggregates made from PEI-PLGA diblock copolymers: micellar characteristics and cellular uptake. Biomaterials 2003; 24:2053-9. [PMID: 12628825]
26. Suárez F, Jockovich ME, Hernandez E, Feuer W, Parel JM, Murray TG. Paclitaxel in the treatment of retinal tumors of LH beta-Tag murine transgenic model of retinoblastoma. Invest Ophthalmol Vis Sci 2007; 48:3437-40. [PMID: 17652710]
27. Drago-Ferrante R, Santulli A, Di Fiore R, Giuliano M, Calvaruso G, Tesoriere G, Vento R. Low doses of paclitaxel potently induce apoptosis in human retinoblastoma Y79 cells by up-regulating E2F1. Int J Oncol 2008; 33:677-87. [PMID: 18813780]
28. Ayalasomayajula SP, Kompella UB. Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model. Eur J Pharmacol 2005; 511:191-8. [PMID: 15792788]
29. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J. Human ICE/CED-3 protease nomenclature. Cell 1996; 87:171. [PMID: 8861900]